Modular Finance IR Consensus: XVIVO Perfusion – Consensus estimates Q2 2025
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
Number of contributors: 6 (all of which have been updated or confirmed before the report)
| KPI (MSEK, unless otherwise specified) | Q2 2025E |
| Net sales | 224 |
| Organic growth in local currency (%) | 11.60 |
| Gross profit | 166 |
| EBITDA | 46.5 |
| EBIT | 28.7 |
| Net profit | 17.8 |
| Earnings per share (SEK) | 0.55 |
XVIVO Perfusion’s Q2 report will be released on Friday, 11 July 2025 at 07.30 CEST.